Advertisement

Picture EBD Group Partnering Events Spring 2018 CBPF18 BES18 BEE18 600x060px
Organisation › Details

Transgene S.A. (Euronext: TNG)

Transgene is a France-based biopharmaceutical company focused on the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases. The Company has four compounds in Phase II clinical trials: TG4010, JX594/TG6006, TG4001/RG3484 and TG4040 and one compound in Phase I clinical trial: TG4023. Transgene has entered into strategic collaborative agreements for the development of two of its immunotherapy products: - An option agreement with Novartis for an exclusive license to develop TG4010 for the treatment of various cancers, including non small cell lung cancer (NSCLC) - An in-licensing agreement with US-based Jennerex Biotherapeutics, Inc., to develop and market JX594 (JX594/TG6006), an oncolytic product. Transgene has bio-manufacturing capacities for viral-based vectors. *

 

Period Start 1979-01-01 established
  Group Mérieux (Group)
Products Industry therapeutic vaccine
  Industry 2 immunotherapy
Person Person Archinard, Philippe (Transgene 200512 CEO)
     
Region Region Strasbourg
  Country France
  Street Boulevard Gonthier d’Andernach
  City 67405 Illkirch
  Tel +33-3-8827-9100
  Fax +33-3-8827-9111
     
Basic data Employees D: 101 to 500 (2006-12-31)
  Currency EUR
  Annual sales 28,019,000 (revenues, total (2007) 2007-12-31)
  Profit -5,521,000 (2007-12-31)
  Cash 84,100,000 (2014-09-30)
     
    * Document for »About Section«: 
     
   
Record changed: 2017-10-15

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Mérieux (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture EBD Group Partnering Events Spring 2018 CBPF18 BES18 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 120x180px